A detailed history of Atom Investors LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Atom Investors LP holds 259 shares of REGN stock, worth $185,047. This represents 0.03% of its overall portfolio holdings.

Number of Shares
259
Previous 285 9.12%
Holding current value
$185,047
Previous $299,000 9.03%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $26,626 - $31,245
-26 Reduced 9.12%
259 $272,000
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $1.78 Million - $2.16 Million
-2,012 Reduced 87.59%
285 $299,000
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $2.07 Million - $2.28 Million
2,297 New
2,297 $2.21 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $189,176 - $229,897
278 New
278 $228,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.